跳轉至內容
Merck
全部照片(1)

Key Documents

AB3849-I

Sigma-Aldrich

抗磷酸SMAD2抗体(Ser465/467)

from rabbit, purified by affinity chromatography

同義詞:

Mothers against decapentaplegic homolog 2, Ser465/467 phosphorylated, hMAD-2, Ser465/467 phosphorylated, hSMAD2, Ser465/467 phosphorylated, JV18-1, Ser465/467 phosphorylated, MAD homolog 2, Ser465/467 phosphorylated, Mad-related protein 2, Ser465/467 pho

登入查看組織和合約定價


About This Item

分類程式碼代碼:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物源

rabbit

品質等級

抗體表格

affinity isolated antibody

抗體產品種類

primary antibodies

無性繁殖

polyclonal

純化經由

affinity chromatography

物種活性

human

物種活性(以同源性預測)

zebrafish (based on 100% sequence homology), Xenopus (based on 100% sequence homology), mouse (based on 100% sequence homology), bovine (based on 100% sequence homology), chicken (based on 100% sequence homology), rat (based on 100% sequence homology)

技術

western blot: suitable

NCBI登錄號

UniProt登錄號

運輸包裝

wet ice

目標翻譯後修改

phosphorylation (pSer465/pSer467 )

基因資訊

human ... SMAD2(4087)

一般說明

母亲抗decapentaplegic同源物2(UniProt Q15796;也称为hMAD-2,hSMAD2,JV18-1,MAD同源物2,Mad相关蛋白2,母亲抗DPP同源物2,SMAD 2,SMAD家族成员2,Smad2)由人的SMAD2(也称为MADH2,MADR2)基因(基因ID 4087)编码。Smad2是通过转化生长因子TGF-β和激活素1型受体激酶激活的受体调节的细胞内信号转换器和转录调节剂。响应于TGF-β信号,smad2通过其与受体激活(SARA)蛋白的SMAD锚的相互作用而被募集到活化的TGF-β受体,其中它被TGF-β受体磷酸化。磷酸化导致其从SARA分离,并与另一个家族成员smad4结合。然后,smad2-smad4复合物易位到细胞核中,在细胞核中它与靶启动子结合并与其他辅因子形成转录阻遏物复合物。Smad2也可以被激活素1型受体激酶磷酸化,从而转导激活素依赖性信号传导事件。

特異性

该抗体可识别TGFβ刺激的HepG2细胞(而非未刺激的HepG2细胞)中的Smad2 Ser465/467磷酸化。选择性剪接的人Smad2Deltaexon3(短亚型)中相应的目标磷酸丝氨酸残基是pSer435 &pSer437(UniProt Q15796-2)。

免疫原

KLH偶联的合成磷酸肽,对应于人Smad2的Ser465/467周围的残基。
表位:磷酸-Ser465/467。

應用

抗磷酸SMAD2抗体(Ser465/467)是用于蛋白质印迹的针对磷酸SMAD2的抗体。
研究子类别
转录因子
研究类别
表观遗传学&核功能

品質

通过蛋白质印迹对HepG2细胞裂解液进行了评估。

蛋白质印迹分析:2.0 µg/mL该抗体在10 µg经TGFβ刺激而非未刺激的HepG2细胞裂解物中检测到Smad2 Ser465/467磷酸化。

標靶描述

计算值~53kDa 52.31 kDa(长亚型)和48.96 kDa(短亚型;Smad2Deltaexon3)。

聯結

替代品:AB3849

外觀

亲和纯化
纯化的兔多克隆抗体,溶于含有0.1 M Tris-甘氨酸(pH 7.4)、150 mM NaCl和0.05%叠氮化钠的缓冲液中。

儲存和穩定性

自收到之日起,在 2-8°C 条件下可稳定保存1年

其他說明

浓度:请参考特定批次的数据表。

免責聲明

除非我们的产品目录或产品附带的其他公司文档另有说明,否则我们的产品仅供研究使用,不得用于任何其他目的,包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或任何类型的消费或应用于人类或动物。

未找到適合的產品?  

試用我們的產品選擇工具.

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類(WGK)

WGK 1

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Ksenia M Yegodayev et al.
Cancers, 12(2) (2020-02-08)
Most head and neck cancer (HNC) patients are resistant to cetuximab, an antibody against the epidermal growth factor receptor. Such therapy resistance is known to be mediated, in part, by stromal cells surrounding the tumor cells; however, the mechanisms underlying
Eoin D O'Sullivan et al.
JCI insight, 7(22) (2022-12-13)
Progressive fibrosis and maladaptive organ repair result in significant morbidity and millions of premature deaths annually. Senescent cells accumulate with aging and after injury and are implicated in organ fibrosis, but the mechanisms by which senescence influences repair are poorly
Shannon Romano et al.
Development (Cambridge, England), 147(18) (2020-09-09)
Sex determination and differentiation is a complex process regulated by multiple factors, including factors from the germline or surrounding somatic tissue. In zebrafish, sex-determination involves establishment of a bipotential ovary that undergoes sex-specific differentiation and maintenance to form the functional
Erez Hanael et al.
Epilepsia, 60(5), 1005-1016 (2019-04-30)
Dogs with spontaneous or acquired epilepsy exhibit resemblance in etiology and disease course to humans, potentially offering a translational model of the human disease. Blood-brain barrier dysfunction (BBBD) has been shown to partake in epileptogenesis in experimental models of epilepsy.
Xia Ding et al.
Scientific reports, 12(1), 12501-12501 (2022-07-22)
The synthetic lethal association between BRCA deficiency and poly (ADP-ribose) polymerase (PARP) inhibition supports PARP inhibitor (PARPi) clinical efficacy in BRCA-mutated tumors. PARPis also demonstrate activity in non-BRCA mutated tumors presumably through induction of PARP1-DNA trapping. Despite pronounced clinical response

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務